Expertise: Clinical Trials
#prevention #clinicaltrials #cohorts #drugdiscovery #riskfactors #neuroimaging #pharmacology #exercise #nutrition #pollution #nursing #psychiatry #immunology #lifestyle #psychology #cognition #healthyageing #livingwell #stroke #mentalhealth #wayfinding
#prevention #clinicaltrials #cohorts #riskfactors #cognition
Craig is the Professor of Psychiatry of Ageing at the University of Edinburgh, Director of Edinburgh Dementia Prevention and Director of Brain Health Scotland.
Craig is internationally renowned for his work on the design and prosecution of clinical trials. He has been Principal Investigator for almost 30 commercial trials in Alzheimer’s disease, National Chief Investigator for 15 in the UK and Global Coordinating Investigator on 6.
Craig’s research focuses on early detection of disease and the promotion of brain health throughout the life-course to mitigate risks for development and progression of brain diseases that lead to dementia.
Craig is Chair of the Scottish Dementia Research Consortium (SDRC) and Chief Investigator of the European Prevention of Alzheimer’s Dementia (EPAD) Consortium and the PREVENT Dementia Programme.
Prof Craig Ritchie
Dr Vanessa Raymont
Vanessa is an academic old age psychiatrist working at the University of Oxford with a long standing interest in the late life cognitive effects of traumatic brain injury (TBI), as well as clinical trials in cognitive disorders and dementia.
Vanessa leads a number of studies focused on dementia prevention and is part of the Oxford Brain Health Clinic initiative. Vanessa is also director of the Oxford Brain Health Clinical Trials Unit, an associate director for Dementias Platforms UK2 and Dementia and Mental Health Lead for the Thames Valley and South Midlands Clinical Research Network.
Dr Terry Quinn
Terry holds the post of Senior Clinical Lecturer and Honorary Consultant Physician in Stroke. Terry has a broad research portfolio, his principal research interests are around trial methodology, functional assessment and neuropsychological consequences of cardiovascular disease.
Terry has published extensively on topics relating to stroke, cognition and test accuracy and has authored original research, opinion pieces and editorials for journals such as British Medical Journal; Journal of the American Medical Association and New England Journal of Medicine.
He is Principal Investigator for a number of studies and holds the inaugural CSO/Stroke Association priority program grant for his research into cognitive outcomes following stroke.
Terry is passionate about evidence based practice and has worked to raise standards in clinical research involving older adults. He holds editorial board positions with various journals, he is coordinating editor for the Cochrane Dementia Group; member of the Dementia Platforms UK vascular theme and part of the NIHR Complex Reviews Support Unit.
Communicating science is a particular strength and in his role working with patient, carers and lay public, as lead for the Scottish Stroke Research Network he has initiated a number of schemes around research dissemination and involvement. As clinical member of the Scottish Parliament Cross Party Group on Heart Disease and Stroke and advisor to Healthcare Improvement Scotland, Terry has ensured that research results inform policy. A recent example is his role as medical advisor to the National report on atrial fibrillation.
Terry combines his research portfolio with active teaching and clinical commitments in the stroke units of the major Glasgow hospitals.
Dr Tim Wilkinson
Tim is a neurologist and clinical lecturer in Edinburgh. He completed his PhD in Epidemiology at the University of Edinburgh in 2020. Tim's research focuses on the use of routinely-collected healthcare datasets (such as primary care and hospital admissions data) to better understand ways in which we can prevent dementia.
He co-created the SAIL Dementia e-Cohort (SAIL-DeC). SAIL-DeC is a 'virtual' cohort created from Welsh routine data to facilitate epidemiological dementia research.
Sarah is a part-time PhD student studying the associations between the risk for Alzheimer's disease and HPA axis (stress response) dysfunction in mid and later life.
Sarah has a BSc in Psychology and an MSc in Mental Health Science Research.
Sarah also works as a study coordinator with over 10 years of experience managing complex interventional and observational studies in mental health, dementia, mild cognitive impairment and healthy ageing.
Stina is an early career researcher with an interest in pre-dementia stages. Stina's PhD is a longitudinal cohort study looking at the short-term and longer term impact of communicating about mild cognitive impairment.
Stina's educational background is in Clinical Psychology (MRes; MSc and BA) and in parallel to her PhD studies, Stina works in Alzheimer's disease clinical trials at the University of Edinburgh and leads the ePSOM project, developing an outcome measure for capturing meaningful changes in Alzheimer's disease clinical trials.